APA (7th ed.) Citation

L, C., D, R., M, L., J, R., J, C., D, P., . . . R, K. (2022). Dysregulation of immune cell and cytokine signalling correlates with clinical outcomes in myelodysplastic syndrome (MDS). European journal of haematology, 108(4), 342. https://doi.org/10.1111/ejh.13742

Chicago Style (17th ed.) Citation

L, Chee, Ritchie D, Ludford-Menting M, Ripley J, Chung J, Park D, Norton S, Kenealy M, and Koldej R. "Dysregulation of Immune Cell and Cytokine Signalling Correlates with Clinical Outcomes in Myelodysplastic Syndrome (MDS)." European Journal of Haematology 108, no. 4 (2022): 342. https://doi.org/10.1111/ejh.13742.

MLA (9th ed.) Citation

L, Chee, et al. "Dysregulation of Immune Cell and Cytokine Signalling Correlates with Clinical Outcomes in Myelodysplastic Syndrome (MDS)." European Journal of Haematology, vol. 108, no. 4, 2022, p. 342, https://doi.org/10.1111/ejh.13742.